Correlation of Molecular Markers With Response to Therapy and Breast Cancer Behavior
UNC Lineberger Comprehensive Cancer Center
10,000 participants
Dec 1, 1998
OBSERVATIONAL
Conditions
Summary
RATIONALE: Studying samples of tumor tissue and blood from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. It may also help doctors predict how patients will respond to treatment. PURPOSE: This research study is looking at tissue and blood samples from women with locally advanced or metastatic breast cancer
Eligibility
Plain Language Summary
Simplified for easier understanding
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
approximately 16-20 milligrams of tumor tissue per core will be obtained for research purposes.
Evaluation of biomarkers will occur as questions are asked in subsequent correlative studies.
cancer tissue will be taken from the primary breast cancer site as well as the metastatic tumor sites. Two tubes of whole blood will also be collected.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT01000883